An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

ConclusionThis study provides technical feasibility data for correlative studies. Tissue biopsies provide distinct data from the blood and may predict response to pembrolizumab.

Source: Journal for Immunotherapy of Cancer - March 12, 2019 Category: Cancer & Oncology Source Type: research